Literature DB >> 23814606

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial.

Carly Eckard1, Renee Cole, Joshua Lockwood, Dawn M Torres, Christopher D Williams, Janet C Shaw, Stephen A Harrison.   

Abstract

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is now recognized as part of the metabolic syndrome, and is specifically related to obesity and insulin resistance. Lifestyle modification is advocated for the treatment of NAFLD, but few studies have evaluated its impact on liver histology. The purpose of this study was to investigate which, if any, specific diet and exercise recommendations are associated with histopathologic changes.
METHODS: A total of 56 participants were randomly assigned to 1 of 4 lifestyle modification subgroups for 6 months: standard care, low-fat diet and moderate exercise, moderate-fat/low-processed-carbohydrate diet and moderate exercise, or moderate exercise only. All subjects had biopsy-proven NAFLD, to include nonalcoholic steatohepatitis (NASH), and received a repeat 6-month biopsy to detect histopathologic changes. Other measures included blood assay of liver enzymes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase), fasting glucose, serum insulin, lipid panel, body weight, dietary intake, fat mass, and fitness level.
RESULTS: Among the 41 participants who completed the study (88% with NASH), a significant change was found in pre- to post-NAFLD activity score in the group as a whole (p < 0.001) with no difference detected between subgroups (p = 0.31). Our results confirm that lifestyle modification is effective in improving NAFLD and NASH.
CONCLUSIONS: Regardless of intervention group, lifestyle modification improved liver histology, as verified by repeat biopsy, after a 6-month intervention. This study reinforces the importance of lifestyle modification as the primary treatment strategy for patients with NAFLD.

Entities:  

Keywords:  NAFLD; diabetes; diet; fatty liver; lifestyle modification; low fat; treatment

Year:  2013        PMID: 23814606      PMCID: PMC3667474          DOI: 10.1177/1756283X13484078

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  45 in total

1.  Body mass index and waist circumference in non-alcoholic fatty liver disease.

Authors:  R Rocha; H P Cotrim; F M Carvalho; A C Siqueira; H Braga; L A Freitas
Journal:  J Hum Nutr Diet       Date:  2005-10       Impact factor: 3.089

2.  Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

3.  Position of the American Dietetic Association: weight management.

Authors:  Helen M Seagle; Gladys Witt Strain; Angela Makris; Rebecca S Reeves
Journal:  J Am Diet Assoc       Date:  2009-02

Review 4.  Steatohepatitis in obese individuals.

Authors:  Wael I Youssef; Arthur J McCullough
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

5.  The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

Authors:  David Tendler; Sauyu Lin; William S Yancy; John Mavropoulos; Pam Sylvestre; Don C Rockey; Eric C Westman
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

6.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention.

Authors:  Jirí Hrebícek; Vladimír Janout; Jana Malincíková; Dagmar Horáková; Ludek Cízek
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Dietary fat content modifies liver fat in overweight nondiabetic subjects.

Authors:  Jukka Westerbacka; Katriina Lammi; Anna-Maija Häkkinen; Aila Rissanen; Irma Salminen; Antti Aro; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

Review 9.  Effects of weight loss on nonalcoholic fatty liver disease.

Authors:  Nila Rafiq; Zobair M Younossi
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

10.  Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects.

Authors:  Fumihiko Sato; Yoshifumi Tamura; Hirotaka Watada; Naoki Kumashiro; Yasuhiro Igarashi; Hiroshi Uchino; Tadayuki Maehara; Shinsuke Kyogoku; Satoshi Sunayama; Hiroyuki Sato; Takahisa Hirose; Yasushi Tanaka; Ryuzo Kawamori
Journal:  J Clin Endocrinol Metab       Date:  2007-05-22       Impact factor: 5.958

View more
  39 in total

1.  Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.

Authors:  B G P Koot; O H van der Baan-Slootweg; S Vinke; A E Bohte; C L J Tamminga-Smeulders; P L M Jansen; J Stoker; M A Benninga
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

Review 2.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

Review 3.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

Review 4.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

Review 5.  Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?

Authors:  Bülent Baran; Filiz Akyüz
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 6.  Non-Alcoholic Fatty Liver Disease, an Overview.

Authors:  Asia Muhammad Nd
Journal:  Integr Med (Encinitas)       Date:  2019-04

Review 7.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

Review 9.  Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.

Authors:  Pegah Golabi; Cameron T Locklear; Patrick Austin; Sophie Afdhal; Melinda Byrns; Lynn Gerber; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 10.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.